BioScience Health Innovations, Inc.
BHIC
$1.00
-$8.01-88.90%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 43.22% | 101.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 43.22% | 101.10% | |||
| Cost of Revenue | 106.41% | 22.01% | |||
| Gross Profit | 19.91% | 164.34% | |||
| SG&A Expenses | 31.43% | 42.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 62.41% | 33.32% | |||
| Operating Income | 7.24% | 4,168.00% | |||
| Income Before Tax | 7.24% | 4,168.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 7.24% | 4,168.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.24% | 4,168.00% | |||
| EBIT | 7.24% | 4,168.00% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 7.22% | 4,750.00% | |||
| Normalized Basic EPS | 6.56% | 6,000.00% | |||
| EPS Diluted | 3.09% | 4,750.00% | |||
| Normalized Diluted EPS | 8.33% | 5,900.00% | |||
| Average Basic Shares Outstanding | 0.00% | 2.96% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||